EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 350 filers reported holding EXELIXIS INC in Q4 2020. The put-call ratio across all filers is 2.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $58,780,000 | +3.0% | 2,404,100 | 0.0% | 0.74% | -8.1% |
| Q2 2020 | $57,073,000 | +4.2% | 2,404,100 | -24.4% | 0.80% | -12.6% |
| Q1 2020 | $54,761,000 | -17.2% | 3,180,100 | -15.3% | 0.92% | -2.5% |
| Q4 2019 | $66,140,000 | -4.4% | 3,753,700 | -4.1% | 0.94% | -28.1% |
| Q3 2019 | $69,200,000 | -17.2% | 3,912,900 | 0.0% | 1.31% | +1.4% |
| Q2 2019 | $83,619,000 | +25.4% | 3,912,900 | +39.7% | 1.30% | +25.5% |
| Q1 2019 | $66,685,000 | +21.0% | 2,801,900 | 0.0% | 1.03% | +1.3% |
| Q4 2018 | $55,113,000 | +11.0% | 2,801,900 | 0.0% | 1.02% | +70.4% |
| Q3 2018 | $49,650,000 | +37.2% | 2,801,900 | +66.7% | 0.60% | +38.4% |
| Q2 2018 | $36,179,000 | +988.7% | 1,681,200 | +1020.8% | 0.43% | +953.7% |
| Q1 2018 | $3,323,000 | -95.8% | 150,000 | -97.6% | 0.04% | -95.5% |
| Q3 2016 | $79,379,000 | +676.4% | 6,206,300 | +114.9% | 0.90% | +617.5% |
| Q1 2014 | $10,224,000 | -82.2% | 2,888,000 | -69.2% | 0.13% | -85.1% |
| Q4 2013 | $57,555,000 | +13.1% | 9,389,000 | +7.4% | 0.85% | -6.8% |
| Q3 2013 | $50,890,000 | – | 8,744,000 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 15,001,073 | $265,294,000 | 64.62% |
| Sargent Investment Group, LLC | 465,620 | $8,234,000 | 3.70% |
| Orbimed Advisors | 3,912,900 | $69,200,000 | 1.31% |
| Bellevue Group AG | 3,858,700 | $68,241,000 | 1.27% |
| TEALWOOD ASSET MANAGEMENT INC | 137,129 | $2,425,000 | 1.04% |
| CAPITAL MANAGEMENT CORP /VA | 200,995 | $3,555,000 | 0.97% |
| Penn Capital Management Company, LLC | 517,988 | $9,161,000 | 0.96% |
| Chicago Capital, LLC | 801,560 | $14,176,000 | 0.95% |
| Portolan Capital Management | 454,444 | $8,037,000 | 0.91% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,534 | $1,830,000 | 0.85% |